{
  "id": "550c44d1a103b7801600000a",
  "type": "yesno",
  "question": "Is PLK2 involved in alpha-synuclein phosphorylation in the nervous system?",
  "ideal_answer": "Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in the central nervous system.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21162130",
    "http://www.ncbi.nlm.nih.gov/pubmed/21838679",
    "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
    "http://www.ncbi.nlm.nih.gov/pubmed/19889641",
    "http://www.ncbi.nlm.nih.gov/pubmed/24128992",
    "http://www.ncbi.nlm.nih.gov/pubmed/23794260",
    "http://www.ncbi.nlm.nih.gov/pubmed/19004816"
  ],
  "snippets": [
    {
      "text": "Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inhibitors of PLK kinases inhibited alpha-synuclein phosphorylation both in primary cortical cell cultures and in mouse brain in vivo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "specific knockdown of PLK2 expression by transduction with short hairpin RNA constructs or by knock-out of the plk2 gene reduced p-Ser-129 levels",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two of these kinases stand out as potential drug targets for novel PD therapy, namely leucine rich repeat kinase 2 (LRRK2) and the alpha-synuclein (\u03b1-syn) phosphorylating polo-like kinase 2 (PLK2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21838679",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Also, due to the dominant mode of \u03b1-syn and LRRK2 inheritance and based on current knowledge of LRRK2 and \u03b1-syn phosphorylation by PLK2, inhibition of LRRK2 and PLK2 may constitute a potential therapy for PD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21838679",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To better understand the role of PLK2 in \u03b1-synuclein phosphorylation in vivo, we further evaluated the effect of PLK2 genetic knockdown and pharmacological inhibition on Phospho-\u03b1-Syn levels in different brain regions of PLK2 knockout (KO), heterozygous (Het) and wild-type (WT) mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24128992",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This PLK2-mediated neuroprotective effect is also dependent on PLK2 activity and \u03b1-synuclein phosphorylation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PLK2-mediated degradation of \u03b1-synuclein requires both phosphorylation at S129 and PLK2/\u03b1-synuclein complex formation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overexpression of only PLK2 increased phosphorylation of aggregated \u03b1-syn at S129, which likely is due to increased phosphorylation of soluble \u03b1-syn, which then was incorporated into aggregates.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21162130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Unlike other kinases reported to partially phosphorylate alpha-syn at Ser-129 in vitro, phosphorylation by PLK2 and PLK3 is quantitative (",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19889641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inhibitors of PLK kinases inhibited alpha-synuclein phosphorylation both in primary cortical cell cultures and in mouse brain in vivo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inhibitors of PLK kinases inhibited alpha-synuclein phosphorylation both in primary cortical cell cultures and in mouse brain in vivo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To better understand the role of PLK2 in \u03b1-synuclein phosphorylation in vivo, we further evaluated the effect of PLK2 genetic knockdown and pharmacological inhibition on Phospho-\u03b1-Syn levels in different brain regions of PLK2 knockout (KO), heterozygous (Het) and wild-type (WT) mice",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24128992",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Polo-like kinase-2 (Plk-2) has been implicated as the dominant kinase involved in the phosphorylation of \u03b1-synuclein in Lewy bodies, which are one of the hallmarks of Parkinson's disease neuropathology",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23794260",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/SYUA_SERCA",
    "http://www.uniprot.org/uniprot/SYUA_ERYPA",
    "http://www.uniprot.org/uniprot/SYUA_GORGO",
    "http://www.uniprot.org/uniprot/SYUA_PANPA",
    "http://www.uniprot.org/uniprot/SYUA_ATEGE",
    "http://www.uniprot.org/uniprot/SYUA_RAT",
    "http://www.uniprot.org/uniprot/SYUA_PONAB",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051844",
    "http://www.uniprot.org/uniprot/PLK2_PONAB",
    "http://www.uniprot.org/uniprot/SYUA_HUMAN"
  ],
  "exact_answer": "Yes"
}